References and Citations:

1. Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51:3353–3361. [PubMed]

2. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg. 2002;104:182–191. [PubMed]

3. Kim MS, Polychronakos C. Immunogenetics of type 1 diabetes. Horm Res. 2005;64:180–188. [PubMed]

4. Kyvik KO, Green A, Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. Br Med J. 1995;311:913–917. [PubMed]

5. Strachan DP. Hay fever, hygiene, and household size. Br Med J. 1989;299:1259–1260. [PubMed]

6. Chan-Yeung M, et al. The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China. Eur Respir J. 2002;19:853–858. [PubMed]

7. Perzanowski MS, et al. Atopy, asthma, and antibodies to Ascaris among rural and urban children in Kenya. J Pediatr. 2002;140:582–588. [PubMed]

8. Dunne DW, Cooke A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol. 2005;5:420–426. [PubMed]

9. Weinstock JV, et al. The possible link between de-worming and the emergence of immunological disease. J Lab Clin Med. 2002;139:334–338. [PubMed]

10. Kamradt T, Goggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol. 2005;26:260–267. [PubMed]

11. Cooke A, et al. Infection and autoimmunity: are we winning the war, only to lose the peace? Trends Parasitol. 2004;20:316–321. [PubMed]

12. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911–920. [PubMed]

13. Wilfing A, et al. African–European differences in the capacity of T-cell cytokine production. Am J Trop Med Hyg. 2001;65:504–509. [PubMed]

14. Banting FG, Best CH. Pancreatic extracts. 1922. J Lab Clin Med. 1990;115:254–272. [PubMed]

15. She JX. Susceptibility to type I diabetes: HLA-DQ DR revisited. Immunol Today. 1996;17:323–329. [PubMed]

16. Todd JA. Genetic control of autoimmunity in type 1 diabetes. Immunol Today. 1990;11:122–129. [PubMed]

17. Papadopoulos GK. Genetics of type I diabetes. Immunol Today. 1998;19:288–289. [PubMed]

18. Barker, JM. Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening. J Clin Endocrinol Metab. 2006.

19. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet. 2000;355:873–876. [PubMed]

20. Marrosu MG, et al. The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone. Hum Mol Genet. 2004;13:2919–2924. [PubMed]

21. Joner G, Stene LC, Sovik O. Nationwide, prospective registration of type 1 diabetes in children aged < 15 years in Norway 1989–98: no increase but significant regional variation in incidence. Diabetes Care. 2004;27:1618–1622. [PubMed]

22. Moussa MA, et al. Prevalence of type 1 diabetes among 6- to 18-year-old Kuwaiti children. Med Princ Pract. 2005;14:87–91. [PubMed]

23. Moussa MA, et al. Factors associated with type 1 diabetes in Kuwaiti children. Acta Diabetol. 2005;42:129–137. [PubMed]

24. Ionescu-Tirgoviste C, et al. An increasing trend in the incidence of type 1 diabetes mellitus in children aged 0–14 years in Romania – ten years (1988–97) EURODIAB study experience. J Pediatr Endocrinol Metab. 2004;17:983–991. [PubMed]

25. Makino S, et al. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 1980;29:1–13. [PubMed]

26. Leiter EH, Serreze DV, Prochazka M. The genetics and epidemiology of diabetes in NOD mice. Immunol Today. 1990;11:147–149. [PubMed]

27. Hutchings P, et al. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature. 1990;348:639–642. [PubMed]

28. Rosmalen JG, et al. Dendritic cells in the autoimmune insulitis in NOD mouse models of diabetes. Adv Exp Med Biol. 1997;417:291–294. [PubMed]

29. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol. 1992;51:285–322. [PubMed]

30. Oldstone MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science. 1988;239:500–502. [PubMed]

31. Cooke A, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 1999;21:169–176. [PubMed]

32. Zaccone P, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol. 2003;33:1439–1449. [PubMed]

33. Baxter AG, et al. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology. 1994;83:227–231. [PubMed]

34. Bras A, Aguas AP. Diabetes-prone NOD mice are resistant to Mycobacterium

avium and the infection prevents autoimmune disease. Immunology. 1996;89:20–25. [PubMed]

35. Zaccone P, et al. Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Eur J Immunol. 2004;34:3246–3256. [PubMed]

36. Wilberz S, et al. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia. 1991;34:2–5. [PubMed]

37. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol. 2003;3:733–744. [PubMed]

38. Maizels RM, et al. Helminth parasites – masters of regulation. Immunol Rev. 2004;201:89–116. [PubMed]

39. van Die I, et al. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology. 2003;13:471–478. [PubMed]

40. van Kooyk Y, Geijtenbeek TB. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol. 2003;3:697–709. [PubMed]

41. Hernandez HJ, Wang Y, Stadecker MJ. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation. J Immunol. 1997;158:4832–4837. [PubMed]

42. Wilson MS, et al. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med. 2005;202:1199–1212. [PubMed]

43. Okano M, et al. Lacto-n-fucopentaose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J Immunol. 2001;167:442–450. [PubMed]

44. Hesse M, et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol. 2004;172:3157–3166. [PubMed]

45. McKee AS, Pearce EJ. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol. 2004;173:1224–1231. [PubMed]

46. Duez C, Gosset P, Tonnel AB. Dendritic cells and toll-like receptors in allergy and asthma. Eur J Dermatol. 2006;16:12–16. [PubMed]

47. Thomas PG, et al. A helminth glycan induces APC maturation via alternative NF-kappa B activation independent of I kappa B alpha degradation. J Immunol. 2005;175:2082–2090. [PubMed]

48. Kane CM, et al. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol. 2004;173:7454–7461. [PubMed]

49. Herbert DR, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity. 2004;20:623–635. [PubMed]

50. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol. 2005;23:877–900. [PubMed]

51. Faveeuw C, et al. Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice. J Immunol. 2002;169:906–912. [PubMed]

52. Pearce EJ, et al. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol Rev. 2004;201:117–126. [PubMed]

53. Freeman CM, et al. CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice. J Immunol. 2005;174:1962–1970. [PubMed]

54. Jenkins SJ, Mountford AP. Dendritic cells activated with products released by schistosome larvae drive Th2-type immune responses, which can be inhibited by manipulation of CD40 costimulation. Infect Immun. 2005;73:395–402. [PubMed]

55. Taylor MD, et al. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol. 2005;174:4924–4933. [PubMed]

56. Belkaid Y, et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420:502–507. [PubMed]

57. La Flamme AC, Ruddenklau K, Backstrom BT. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun. 2003;71:4996–5004. [PubMed]

58. Nagayama Y, et al. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves’ hyperthyroidism. J Immunol. 2004;173:2167–2173. [PubMed]

59. Sewell D, et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol. 2003;15:59–69. [PubMed]

60. Elliott DE, et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2003;284:G385–G391. [PubMed]

61. Khan WI, et al. Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun. 2002;70:5931–5937. [PubMed]

62. Summers RW, et al. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol. 2003;98:2034–2041. [PubMed]

63. Elliott DE, et al. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol. 2004;34:2690–2698. [PubMed]

64. McInnes IB, et al. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol. 2003;171:2127–2133. [PubMed]

65. Weinstock JV, Summers RW, Elliott DE. Role of helminths in regulating mucosal inflammation. Springer Semin Immunopathol. 2005;27:249–271. [PubMed]

66. Summers RW, et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005;128:825–832. [PubMed]

67. Mayer L. A novel approach to the treatment of ulcerative colitis: is it kosher? Gastroenterology. 2005;128:1117–1119. [PubMed]

68. Croese J, et al. A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut. 2006;55:136–137. [PubMed]

69. Borkow G, Bentwich Z. Eradication of helminthic infections may be essential for successful vaccination against HIV and tuberculosis. Bull World Health Organ. 2000;78:1368–1369. [PubMed]

70. McElroy MD, et al. Coinfection with Schistosoma mansoni is associated with decreased HIV-specific cytolysis and increased IL-10 production. J Immunol. 2005;174:5119–5123. [PubMed]

71. Bentwich Z. Concurrent infections that rise the HIV viral load. J HIV Ther. 2003;8:72–75. [PubMed]

72. Braschi S, et al. The tegument surface membranes of the human blood parasite Schistosoma mansoni: A proteomic analysis after differential extraction. Proteomics. 2006;6:1471–1482. [PubMed]

73. Wilson RA, et al. From genomes to vaccines via the proteome. Mem Inst Oswaldo Cruz. 2004;99(5 Suppl. 1):45–50. [PubMed]